Overview
IMCD N.V. is a specialty chemicals and ingredients distributor headquartered in Rotterdam, the Netherlands. It connects producers with customers through sales, marketing, distribution and technical expertise, serving markets including beauty and personal care, food and nutrition, pharmaceuticals, coatings and construction, home care, industrial solutions, advanced materials, and lubricants and energy.[1][2][3]
The company operates across Europe, Asia-Pacific, Africa, and North and Latin America, with a presence in more than 60 countries across six continents. IMCD describes its ambition as “Creating a world of opportunity for our customers, suppliers and employees.” [1][4][5] Founded in Rotterdam in 1995, IMCD reported FY2025 revenue of €4,778.9 million and 5,246 employees (FTE) at year-end.[6][7][8] [1][2][7][8][3][4][5][6]
Products & services
IMCD’s product portfolio spans specialty ingredients and chemicals across Advanced Materials; Beauty & Personal Care; Coatings & Construction; Food & Nutrition; Home Care and I&I; Industrial Solutions; Lubricants & Energy; and Pharmaceuticals. Products include polymers, resins, pigments, additives, surfactants, emulsifiers, hydrocolloids, proteins, vitamins, active ingredients, pharmaceutical APIs and excipients, and solvents; availability varies by market.[3][9][10][11]
Examples include KELCOGEL HM-B, a high-acyl gellan gum used to stabilize neutral-pH dairy beverages and suspend insoluble ingredients, and KELCOGEL BKR, a low-acyl gellan gum used for food stability and texture.[12][13] In personal care, the Glass’Hair Leave-On formulation is presented for hair shine and smoothness and features GREENQUAT® SOCRI, a plant-derived copolymer made from upcycled sugar-beet material for smoothing and hydration.[14] In lubricants, Lubrizol® PV9010 is described as a “5-in-1” engine-oil solution intended to reduce blending complexity.[15]
Services include formulation and application support, performance optimization, troubleshooting, trials and training, supported by application laboratories, pilot plants and technical centres. Pharmaceutical support also includes regulatory and quality expertise; IMCD’s technical hubs include application and bakery labs.[16][17][18][19] IMCD’s public portfolio descriptions generally emphasize product categories and applications; the sources reviewed did not provide product-level revenue shares or individual product performance percentages. [3][9][10][11][12][13][14][15][16][17][18][19]
Geographic presence
IMCD operates in more than 60 countries across six continents. At its 2025 anniversary, the company reported a global network of 110 offices, 80 laboratories and 150 warehouses.[20][4][6]
At year-end 2025, IMCD had 5,246 FTE: 2,283 in EMEA, 1,466 in the Americas and 1,497 in Asia-Pacific.[8] The regional figures represent approximately 43.5%, 28.0% and 28.5% of total FTE, respectively, calculated from the reported counts.[8]
The available HY 2026 regional figures report gross profit rather than revenue: EUR 328 million in EMEA, EUR 176 million in the Americas and EUR 154 million in Asia-Pacific.[21] The reviewed evidence does not provide revenue by country or region. [20][8][8][8][8][21][21][21][4][6]
Business segments
IMCD’s officially reported market segments are **Life Science** and **Industrial**. In the first half of 2026, Life Science generated EUR 1,426.8 million in sales of goods, approximately 54.2% of the EUR 2,631.7 million total. Its focus areas are Pharmaceuticals; Beauty & Personal Care; Food & Nutrition; Home Care; and Industrial & Institutional.[22][23][24] Industrial generated EUR 1,204.8 million, approximately 45.8% of sales of goods, and covers Coatings & Construction; Lubricants & Energy; Industrial Solutions; and Advanced Materials.[22][25][24] The report describes Life Science as historically less sensitive to economic fluctuations, with generally lower order volumes and higher margins than Industrial; it characterises Industrial as more cyclical, with exposure to housing and real estate, automotive, and oil and gas markets.[23][25]
IMCD also reports operating segments by customer geography: EMEA, the Americas, and Asia-Pacific. In the first half of 2026, these represented approximately 46.4%, 27.9%, and 25.6% of consolidated revenue, respectively.[26][27] [22][23][25][24][24][24][26][27]
Company history
IMCD was founded in Rotterdam in 1995 by Piet van der Slikke and Hans Kooijmans, and adopted the IMCD name in 2001.[28][6] In 2013, its acquisition of Brazil’s Makeni Chemicals marked its entry into the Americas.[29][30]
IMCD listed on Euronext Amsterdam on 27 June 2014, and expanded in the United States in 2015 through acquisitions including M.F. Cachat and MJS Sales; it acquired the remaining stake in M.F. Cachat in 2017.[31][32][33] Its shares joined the AEX Index in March 2019.[31] In a later leadership transition, Valerie Diele-Braun succeeded van der Slikke as CEO in January 2024, followed by Marcus Jordan on 24 April 2025.[34][35] [28][31][32][6][29][30][33][34][35]
Sources
- IMCD — Full financial report (2025 Y)
- www.imcdgroup.com[3]
- www.imcdgroup.com[4]
- www.imcdgroup.com[5]
- www.imcdgroup.com[6]
- www.imcdgroup.com[9]
- www.imcdgroup.com[10]
- www.imcdgroup.com[11]
- www.imcdus.com[12]
- www.imcdus.com[13]
- www.imcd.ch[14]
- www2.imcdgroup.com[15]
- www.imcdgroup.com[16]
- www.imcdgroup.com[17]
- www.imcdgroup.com[18]
- www.imcdgroup.com[19]
- IMCD — Presentation (2026 H 1)[21]
- IMCD — Press release (2026 H 1)
- www.imcdgroup.com[29]
- www.imcdgroup.com[30]
- IMCD — Full financial report (2019 Y)[31]
- IMCD — Full financial report (2015 Y)[32]
- www.imcdgroup.com[33]
- www.imcdgroup.com[34]
- www.imcdgroup.com[35]
Continue your research
From company context to financial detail.
Explore original sources and worldwide fundamental financial data and intelligence with Finbar.
Explore IMCD in Finbar ↗